Personalized Cancer Vaccines Market Personalized Cancer Vaccines Clinical Pipeline Report 2022

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

Report Table of Contents

1. Personalized Vaccine: Trail Towards Cancer
1.1 Prologue to Personalized Cancer Immunotherapy
1.2 Advent of Personalized Cancer Vaccine

2. Perception of Personalized Vaccinomics
2.1 Genetic Heterogeneity by HLA System
2.2 Genesis of Tumor Neoantigens

3. Identification of Tumor Neoantigens
3.1 Conventional Methodologies
3.2 Next Genome Sequencing Approach

4. Development of Personalized Vaccines
4.1 Development Process of Personal Cancer Vaccine
4.2 Economic Aspects of Personalized Cancer Vaccine

5. Mechanism of Personalized Vaccines
5.1 Rationale of Personal Cancer Vaccine
5.2 Neoantigens and Immune Interactions

6. Application of Neoantigens in Therapeutics
6.1 Adoptive T Cell Therapy
6.2 Checkpoint Blockade

7. Categories of Personalized Cancer Vaccines
7.1 Personalized Peptide Vaccination (PPV)
7.2 DNA Cancer Vaccines
7.3 RNA Based Vaccines
7.4 Dendritic Cell Vaccines
7.5 Whole Tumor Cell Vaccines
7.6 Recombinant Virus Vaccines


8. Biomarkers for Personalized Vaccines
8.1 Pharmacogenomic Biomarkers
8.2 Prognostic and Predictive Biomarkers
8.3 Immune Checkpoint Biomarkers

9. Personalized Vaccines for Varied Cancers
9.1 Melanoma
9.2 Lung Cancer
9.3 Breast Cancer
9.4 Colorectal Cancer
9.5 Leukemia
9.6 Prostate cancer
9.7 Cervical Cancer
9.8 Gastric Cancer
9.9 Brain Tumor
9.10 Renal Cancer

10. Pharmacogenomics of Personalization
10.1 Pharmacogenomics towards Genomic Polymorphism
10.2 Somatic Mutations in Cancer Pharmacogenomics
10.3 Applications of Pharmacogenomics

11. Personalized Vaccines Market Overview
11.1 Market Trends Towards Therapeutic Personalization
11.2 Mergers and Acquisitions for Personalized Therapy

12. Global Personalized Vaccines Market Dynamics
12.1 Personalization Growth Drivers
12.1.1 Increasing Cancer Incidences
12.1.2 Cancer Heterogenetic Environment
12.1.3 High Level of Specificity
12.1.4 Government Initiatives
12.1.5 Reduced Genome Sequencing Cost and Time
12.1.6 Sustained Level of Innovation
12.2 Personalization Major Challenges

13. Global Personalized Cancer Vaccines Market Future Aspects

14. Competitive Landscape
14.1 Advaxis Inc.
14.2 Avax Technologies
14.3 BioNtech
14.4 Celldex
14.5 Genentech Inc.
14.6 Genocea
14.7 ISA Pharmaceuticals
14.8 Merck and Co.
14.9 Moderna
14.10 Neon Therapeutics

Download Report: https://www.kuickresearch.com/report-personalized-cancer-vaccines-market-and-clinical-innovation-outlook-2022.php

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.